Thinking Outside The Cube
Welcome to the Genomadix™ Blog!
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack Please download the file
csbpr7 Acute Stroke Management Module
Acute stroke management module final Please download the file to learn more.
European Stroke Organisation expedited recommendation for the use of short term dual antiplatelet therapy early after minor stroke and high risk TIA
European Stroke Organisation expedited recommendation for the use of short term dual antiplatelet therapy early after minor stroke and high
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy Please download the file to learn more.
NICE Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack
NICE Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack Please download the file to learn more.
Genotype Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease An Updated Systematic Review and Meta Analysis
Genotype Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease An Updated Systematic Review and Meta Analysis
Guided vs conventional anti-platelet therapy for patients with acute coronary syndrome A meta-analysis of randomized controlled trials
Guided vs conventional anti-platelet therapy for patients with acute coronary syndrome A meta-analysis of randomized controlled trials Please download the
